Summary

● The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

● The company presents an interesting fundamental situation from a short-term investment perspective.

● The company has a good ESG score relative to its sector, according to Refinitiv.


Strengths

● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.

● The company shows low valuation levels, with an enterprise value at 0.42 times its sales.

● The company appears to be poorly valued given its net asset value.

● The company has a low valuation given the cash flows generated by its activity.

● The company is one of the best yield companies with high dividend expectations.

● Over the past year, analysts have regularly revised upwards their sales forecast for the company.

● Sales forecast by analysts have been recently revised upwards.

● For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.

● Over the past twelve months, analysts' opinions have been strongly revised upwards.

● Historically, the company has been releasing figures that are above expectations.


Weaknesses

● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.

● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.

● The company does not generate enough profits, which is an alarming weak point.

● The average consensus view of analysts covering the stock has deteriorated over the past four months.

● The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.